This article was written by Follow With a background as a RN, I analyze healthcare-related stocks by evaluating clinical data, treatment guidelines, and market...
2025 trading behavior prominently featured momentum. Certain categories of stocks soared to new heights while others were left in the dust. Toward the end...
Introduction A new wave of covered call ETFs have swept unsuspecting income investors away with eye-popping distribution rates. The YieldMax TSLA Option Income Strategy...
Welcome to another installment of our CEF Market Weekly Review, where we discuss closed-end fund (“CEF”) market activity from both the bottom-up – highlighting...
At a Glance United Therapeutics’ (NASDAQ:UTHR) Q2 performance underscores robust financials with a notable 27.7% YoY revenue increase, fueling investor optimism. On the clinical...
In a market where bank stocks are out of favor, maybe it makes sense to consider less typical banks, and Westamerica Bancorporation (NASDAQ:WABC) is...